检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈申杰[1] 朱敏[1] 许海宾[1] 黄兆铨[1]
机构地区:[1]浙江省中医院,浙江杭州310000
出 处:《中华中医药学刊》2014年第4期891-892,共2页Chinese Archives of Traditional Chinese Medicine
基 金:浙江省自然科学基金项目(Y13H270037)
摘 要:目的:探讨参附强心丸对慢性心力衰竭(CHF)心功能及对血管紧张素Ⅱ和脑钠素的影响。方法:84例CHF患者随机分为治疗组对照组各42例。对照组采用西医常规治疗,治疗组在西医常规治疗的基础上加用参附强心丸。疗程12周。观察两组心功能分级、检测左室舒张末期内径(LVEDD)、左室舒张末期内径(LVEDD)、N-末端原脑利钠肽(NT-proBNP)及血管紧张素Ⅱ(AngⅡ)。结果:两组治疗后心功能均明显改善,治疗组在降低LVEDD及增加LVEF方面优于对照组(P<0.01);治疗组NT-proBNP、AngⅡ水平均低于对照组(P<0.01);治疗后治疗组MLHFQ评分低于对照组(P<0.01)。结论:参附强心丸能使CHF患者LVEF上升,减小LVEDD,明显改善心功能,提高患者生活质量,其作用机制可能是通过下调BNP和AngⅡ来实现的。Objective : To discuss the effect of Shenfu Qiangxin Pill on cardiac function, Angiotensin Ⅱ and brain sodi- um of chronic heart failure (CHF) patients. Methods :84 patients with CHF were randomly divided into treatment group and control group ( n = 42). The control group treated by routine Western medicine, and the treatment group was given Shenfu Qiangxin Pill on the basis of conventional Western medicine therapy. A course of treatment was 12 weeks. We ob- served the cardiac function classification, detection of left ventricular end - diastolic diameter ( LVEDD), left ventricutar end- diastolic diameter (LVEDD), N- terminal primitive brain natriuretic peptide (NT- proBNP) and Angiotensin Ⅱ (Ang Ⅱ ) of two groups. Results: After the treatment, heart functions of patients were significantly improved in both groups. LVEDD reducing and LVEF increasing in the treatment group were better than that in the control group ( P 〈 0.01 ). The treatment group' s NT - proBNP and Ang Ⅱ levels were lower than those of the control group ( P 〈 0. 01 ). Treatment group's MLHFQ score was lower than that of the control group after treatment (P 〈0.01 ). Conclusion: Shenfu Qiangxin Pill can increase the LVEF and reduce LVEDD, significantly improve cardiac function and improve the patients quality of life. Its mechanism may be through reducing the BNP and Ang Ⅱ.
关 键 词:慢性心力衰竭 参附强心丸 N-末端原脑利钠肽 血管紧张素Ⅱ
分 类 号:R259[医药卫生—中西医结合]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.220.182.171